10945088

Source:http://linkedlifedata.com/resource/pubmed/id/10945088

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists.
Subject	Predicate	Object	Context
pubmed-article:10945088	rdf:type	pubmed:Citation	lld:pubmed
pubmed-article:10945088	lifeskim:mentions	umls-concept:C0456909	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C0008976	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C0003289	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C1545588	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C0449445	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C1511545	lld:lifeskim
pubmed-article:10945088	lifeskim:mentions	umls-concept:C1513040	lld:lifeskim
pubmed-article:10945088	pubmed:dateCreated	2000-8-30	lld:pubmed
pubmed-article:10945088	pubmed:abstractText	Double-blind placebo-controlled trials are the academic standard for clinical psychopharmacology research.	lld:pubmed
pubmed-article:10945088	pubmed:language	eng	lld:pubmed
pubmed-article:10945088	pubmed:journal	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10945088	pubmed:citationSubset	IM	lld:pubmed
pubmed-article:10945088	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10945088	pubmed:chemical	http://linkedlifedata.com/r...	lld:pubmed
pubmed-article:10945088	pubmed:status	MEDLINE	lld:pubmed
pubmed-article:10945088	pubmed:month	Jul	lld:pubmed
pubmed-article:10945088	pubmed:issn	0007-1250	lld:pubmed
pubmed-article:10945088	pubmed:author	pubmed-author:EvesFF	lld:pubmed
pubmed-article:10945088	pubmed:author	pubmed-author:DardennesR...	lld:pubmed
pubmed-article:10945088	pubmed:author	pubmed-author:Siobud-Doroca...	lld:pubmed
pubmed-article:10945088	pubmed:issnType	Print	lld:pubmed
pubmed-article:10945088	pubmed:volume	177	lld:pubmed
pubmed-article:10945088	pubmed:owner	NLM	lld:pubmed
pubmed-article:10945088	pubmed:authorsComplete	Y	lld:pubmed
pubmed-article:10945088	pubmed:pagination	47-51	lld:pubmed
pubmed-article:10945088	pubmed:dateRevised	2007-11-15	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:meshHeading	pubmed-meshheading:10945088...	lld:pubmed
pubmed-article:10945088	pubmed:year	2000	lld:pubmed
pubmed-article:10945088	pubmed:articleTitle	Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.	lld:pubmed
pubmed-article:10945088	pubmed:affiliation	Clinique des Maladies Mentales et de l'Encéphale, Centre Hospitalier Sainte-Anne, Paris, France.	lld:pubmed
pubmed-article:10945088	pubmed:publicationType	Journal Article	lld:pubmed
pubmed-article:10945088	pubmed:publicationType	Review	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10945088	lld:pubmed
http://linkedlifedata.com/r...	pubmed:referesTo	pubmed-article:10945088	lld:pubmed